Management, along with Fumihiko Urano, MD, PhD, Principal Investigator of the HELIOS clinical trial, hold a conference call to discuss interim data from HELIOS, a Phase 2 trial of AMX0035 for treatment of Wolfram syndrome on April 10 at 1:30 pm. amlx/register.aspx?conf=cc&page=amlx&url=https://wsw.com/webcast/cc/amlx/1378476′ target= ‘_blank’; rel=’nofollow’>Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMLX:
